Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...

Pediatric expansion -- Plans are in place to commence a clinical trial for Papzimius in pediatric RRP in Q4 2026. Pipeline ...

Thank you for joining Atour's Fourth Quarter and Full Year 2025 Earnings Call today. In this environment, we are more ...

Good morning, ladies and gentlemen, and welcome to today's Investcorp Credit Management BDC's Quarter ended December 31, 2025 Earnings Call. It is now my pleasure to turn the floor over to Andrew Muns ...

Q4 2025 Earnings Call March 31, 2026 4:30 PM EDTCompany ParticipantsPurva Sanariya - Director of Investor RelationsDavid ...

Carnival Corporation & plc (NYSE:CUK) Q1 2026 Earnings Call Transcript March 27, 2026 Carnival Corporation & plc beats ...

INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.26. Operator: Greetings, and ...

Bruce will then discuss our financial results for the third quarter of 2024 and our guidance for the remainder of fiscal 2024 ...

SPAR Group, Inc. (NASDAQ:SGRP) Q4 2025 Earnings Call Transcript March 31, 2026 SPAR Group, Inc. misses on earnings ...

51Talk Online Education Group (AMEX:COE) Q4 2025 Earnings Call Transcript March 27, 2026 Operator: Hello, ladies and ...

Anticipated mid-60% range, flat year over year, impacted by ongoing bag yield issues and product mix, with improvement expected toward Q4 as remediation measures take effect. ERP rollout -- Newly ...

Creative Media (NASDAQ:CMCT) released fourth-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs.